Philina Lee
Insider Reports History
- Location
- Hamilton, Bermuda
- Signature
- /s/ Virginie Boucinha, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Philina Lee:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Blueprint Medicines Corp | Chief Commercial Officer | Stock Option (Right to Buy) | 0 | $2,104,740 | $95.67 | 17 Jul 2025 | Direct |
| Blueprint Medicines Corp | Chief Commercial Officer | Common Stock | 0 | $0 | $128.18 | 17 Jul 2025 | Direct |
| Fusion Pharmaceuticals Inc. | Director | Stock Option (Right to Buy) | 0 | 04 Jun 2024 | Direct |
Insider Reports Filed by Philina Lee
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| DBVT | DBV Technologies S.A. | 30 Oct 2025 | 0 | $0 | 3 | Director | 16 Apr 2026, 16:51 |
| BPMC | Blueprint Medicines Corp | 17 Jul 2025 | 8 | $0 | 4 | Chief Commercial Officer | 21 Jul 2025, 19:44 |
| BPMC | Blueprint Medicines Corp | 05 Mar 2025 | 1 | -$331,490 | 4 | CHIEF COMMERCIAL OFFICER | 07 Mar 2025, 16:11 |
| BPMC | Blueprint Medicines Corp | 01 Mar 2025 | 2 | $0 | 4 | CHIEF COMMERCIAL OFFICER | 04 Mar 2025, 17:21 |
| BPMC | Blueprint Medicines Corp | 05 Aug 2024 | 15 | -$1,076,952 | 4 | CHIEF COMMERCIAL OFFICER | 07 Aug 2024, 17:06 |
| /report/000095017024068901-lee-philina-2024-06-04 | Fusion Pharmaceuticals Inc. | 04 Jun 2024 | 4 | $0 | 4 | Director | 04 Jun 2024, 17:30 |
| BPMC | Blueprint Medicines Corp | 13 Mar 2024 | 4 | -$702,302 | 4 | CHIEF COMMERCIAL OFFICER | 15 Mar 2024, 16:47 |
| BPMC | Blueprint Medicines Corp | 07 Mar 2024 | 1 | -$266,084 | 4 | CHIEF COMMERCIAL OFFICER | 11 Mar 2024, 18:26 |
| BPMC | Blueprint Medicines Corp | 01 Mar 2024 | 2 | $0 | 4 | CHIEF COMMERCIAL OFFICER | 06 Mar 2024, 16:22 |
| BPMC | Blueprint Medicines Corp | 13 Dec 2023 | 2 | +$488 | 4 | CHIEF COMMERCIAL OFFICER | 14 Feb 2024, 18:54 |
| /report/000120919123037094-lee-philina-2023-06-14 | Fusion Pharmaceuticals Inc. | 14 Jun 2023 | 1 | $0 | 4 | Director | 14 Jun 2023, 17:09 |
| BPMC | Blueprint Medicines Corp | 06 Mar 2023 | 2 | -$76,555 | 4 | CHIEF COMMERCIAL OFFICER | 08 Mar 2023, 20:32 |
| BPMC | Blueprint Medicines Corp | 01 Mar 2023 | 2 | $0 | 4 | CHIEF COMMERCIAL OFFICER | 03 Mar 2023, 19:17 |
| /report/000120919122038772-lee-philina-2022-06-14 | Fusion Pharmaceuticals Inc. | 14 Jun 2022 | 1 | $0 | 4 | Director | 22 Jun 2022, 19:14 |
| BPMC | Blueprint Medicines Corp | 04 Apr 2022 | 0 | $0 | 3 | Chief Commercial Officer | 14 Apr 2022, 16:01 |
| /report/000120919121038580-lee-philina-2021-06-04 | Fusion Pharmaceuticals Inc. | 04 Jun 2021 | 1 | $0 | 4 | Director | 07 Jun 2021, 16:17 |